Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Christopher F.O. GabrieliDirector155,4310.13%2004-05-14
Dr. Spencer R. Berthelsen,M.D.Director50,395less than 0.1%2014-07-01
Mr. Joseph H. WenderDirector37,217less than 0.1%2014-07-01
Dr. Stanley T. Crooke,M.D.,PhDChairman and CEO14,642less than 0.1%2015-01-15
Dr. Douglas L. Cole,PhDVice President9,616less than 0.1%2004-03-05
Ms. B. Lynne Parshall, J.D.COO & Secretary8,072less than 0.1%2015-01-15
Dr. Richard S. Geary,PhDSVP, Development7,570less than 0.1%2015-01-15
Holmlud Jon TN/A7,510less than 0.1%2004-01-01
Dr. C. Frank Bennett,PhDSVP, Antisense Research7,229less than 0.1%2015-01-15
Dr. Mark K. Wedel,M.D.,J.D.N/A6,603less than 0.1%2007-07-06

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
CROOKE STANLEY TChairman and CEO
(Click for the stocks that their CEOs have bought)
2015-01-16Sell9,054725,391$67.96615.36.53Link
Geary Richard SSVP, Development2015-01-16Sell1,5437,570$67.96104.96.53Link
PARSHALL B LYNNECOO & Secretary2015-01-16Sell4,0938,072$67.96278.26.53Link
Monia Brett PSVP, Antisense Drug Discovery2015-01-16Sell1,5344,426$67.96104.36.53Link
HOUGEN ELIZABETH LSVP, Finance & CFO2015-01-16Sell1,2913,387$67.9687.76.53Link
O'NEIL PATRICK R.SVP, Legal & General Counsel2015-01-16Sell1,2916,174$67.9687.76.53Link
BENNETT C FRANKSVP, Antisense Research2015-01-16Sell1,5187,229$67.96103.26.53Link
Geary Richard SSVP, Development2015-01-12Sell5975,064$73.143.6-0.96Link
CROOKE STANLEY TChairman and CEO2015-01-09Sell11,000725,391$73.57809.3-1.59Link
CROOKE STANLEY TChairman and CEO2015-01-07Sell22,000725,391$67.041474.98Link
PARSHALL B LYNNECOO & Secretary2015-01-02Sell11,2004,417$62.12695.716.55Link
O'NEIL PATRICK R.SVP, Legal & General Counsel2015-01-02Sell1,5004,082$62.1293.216.55Link
Monia Brett PSVP, Antisense Drug Discovery2015-01-02Sell761,935$62.754.815.38Link
O'NEIL PATRICK R.SVP, Legal & General Counsel2014-12-01Sell1,5004,253$51.2176.841.38Link
ISIS PHARMACEUTICALS INC10% Owner2014-11-03Sell1,279,4115,516,305$15.9420393.8354.2Link
O'NEIL PATRICK R.SVP, Legal & General Counsel2014-11-03Sell1,5005,253$46.1769.356.81Link
PARSHALL B LYNNECOO & Secretary2014-10-30Sell11,07112,867$45.12499.560.46Link
ISIS PHARMACEUTICALS INCDirector, 10% Owner2014-10-24Sell113,0846,799,266$14.021585.4416.41Link
ISIS PHARMACEUTICALS INCDirector, 10% Owner2014-10-24Sell113,0846,899,517$14.021585.4416.41Link
CROOKE STANLEY TChairman and CEO2014-10-23Sell14,600725,391$42.22616.471.48Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK